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Abstract
Background: Health information technology can enhance self-management and quality of life for patients with
chronic disease and overcome healthcare barriers for patients with limited English proficiency. After a randomized
controlled trial of a multilingual automated telephone self-management support program (ATSM) improved
patient-centered dimensions of diabetes care in safety net clinics, we collaborated with a nonprofit Medicaid
managed care plan to translate research into practice, offering ATSM as a covered benefit and augmenting ATSM
to promote medication activation. This paper describes the protocol of the Self-Management Automated and Real-
Time Telephonic Support Project (SMARTSteps).
Methods/Design: This controlled quasi-experimental trial used a wait-list variant of a stepped wedge design to
enroll 362 adult health plan members with diabetes who speak English, Cantonese, or Spanish and receive care at
4 publicly-funded clinics. Through language-stratified randomization, participants were assigned to four
intervention statuses: SMARTSteps-ONLY, SMARTSteps-PLUS, or wait-list for either intervention. In addition to usual
primary care, intervention participants received 27 weekly calls in their preferred language with rotating queries
and response-triggered education about self-care, medication adherence, safety concerns, psychological issues, and
preventive services. Health coaches from the health plan called patients with out-of-range responses for
collaborative goal setting and action planning. SMARTSteps-PLUS also included health coach calls to promote
medication activation, adherence and intensification, if triggered by ATSM-reported non-adherence, refill non-
adherence from pharmacy claims, or suboptimal cardiometabolic indicators. Wait-list patients crossed-over to
SMARTSteps-ONLY or -PLUS at 6 months. For participants who agreed to structured telephone interviews at
baseline and 6 months (n = 252), primary outcomes will be changes in quality of life and functional status with
secondary outcomes of 6-month changes in self-management behaviors/efficacy and patient-centered processes of
care. We will also evaluate 6-month changes in cardiometabolic (HbA1c, blood pressure, and LDL) and utilization
indicators for all participants.
Discussion: Outcomes will provide evidence regarding real-world implementation of ATSM within a Medicaid
managed care plan serving safety net settings. The evaluation trial will provide insight into translating and scaling
up health information technology interventions for linguistically and culturally diverse vulnerable populations with
chronic disease.
Trial Registration: ClinicalTrials.gov: NCT00683020
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As health systems and public health agencies grapple
with the rising burden of diabetes, they face significant
challenges with the persistent and widening disparities
in the prevalence, quality of care, and clinical outcomes
across such factors as race/ethnicity, language, health lit-
eracy, and socioeconomic status [1-3]. Patient-centered,
culturally concordant care is a cornerstone for reducing
disparities, but vulnerable populations with limited
health literacy and limited English proficiency face bar-
riers to access and communication that place them at
risk for suboptimal treatment management and poor
health outcomes [4-10,10-13].
Self-management support programs are a critical com-
ponent of chronic disease care delivery that can improve
outcomes by providing individualized assessment, colla-
borative goal-setting, skills enhancement, follow-up, and
access to resources and continuity of care [14-16].
Despite the proven benefits of self-management support
and evidence that vulnerable populations desire these
interventions [17], the translational gap between
research and practice may be particularly wide in safety
net settings, which disproportionately care for these
patients [18,19]. Providing self-management support is
resource-intensive, requiring re-training of staff and
organizational change, investments in information tech-
nology, and tailoring programs to engage and serve
diverse populations [20-22]. Thus, traditional self-man-
agement support approaches often do not reach signifi-
cant and growing segments of the chronic disease
population, such as the uninsured or publicly-insured or
those with communication barriers [1,6,17,23-25]. Given
the documented challenges with translating research
into real-world practice, practical implementation and
evaluation research is needed in settings where vulner-
able populations receive care [4,26-31].
Patient-facing health information technology (HIT)
holds promise to increase access to self-management
support and enhance health outcomes for vulnerable
populations in safety net settings [32-34]. Automated
telephone self-management support (ATSM) employs
phone technology to provide surveillance and education
and to prioritize further care management efforts for
those most in need [32]. ATSM can be used to promote
collaborative goal-setting through behavioral action
plans, by which patients set and achieve short-term
goals to improve their self-management [35]. ATSM can
also provide individualized assessment, skills enhance-
ment, live follow-up and support from health educators
or coaches, access to community resources, and conti-
nuity of clinical care [32,33]. The Institute of Medicine
has highlighted ATSM as an exemplary strategy in its
National Action Plan for Health Literacy [36].
The Improving Diabetes Efforts Across Language and
Literacy (IDEALL) study - a randomized controlled trial of
ATSM among English-, Spanish-, and Chinese-speaking
patients with poorly controlled diabetes - demonstrated
high engagement with ATSM, particularly among partici-
pants with limited health literacy and limited English pro-
ficiency [32]. Compared with patients receiving usual care
or group medical visits, patients exposed to ATSM had
greater improvements in their experiences of chronic ill-
ness care, self-management behavior, fewer bed days per
month, less interference in their daily activities, with a cost
utility for functional outcomes comparable to other dia-
betes prevention and treatment interventions [33,37]. We
hypothesized that ATSM could be augmented by harnes-
sing pharmacy claims and clinical registry data, allowing
health coaches to identify patient non-adherence and
missed opportunities for medication intensification and
conduct patient-centered counseling outside of the time-
constrained office visit [38,39]. Given these potential bene-
fits, the San Francisco Health Plan (SFHP) - a non-profit
Medicaid managed care plan serving a diverse, low-income
population - approached our research team at the Univer-
sity of California, San Francisco (UCSF) Center for Vul-
nerable Populations to evaluate the implementation of
ATSM as a covered health benefit for a subset of its mem-
bers with diabetes and add an augmented intervention
harnessing medication claims to promote medication
adherence and intensification.
This paper presents a description of the study design
and recruitment results for the Self-Management Auto-
mated and Real-Time Telephonic Support Study
(SMARTSteps/Pasos Positivos/ 明智進步計劃), a controlled
quasi-experimental evaluation study to improve diabetes
quality of life, self-management, and clinical outcomes
with two variants of language-concordant ATSM inter-
vention implemented by a Medicaid managed care plan
serving a low-income, ethnically diverse urban popula-
tion. We hypothesized that intervention participants
would demonstrate greater improvements in diabetes
self-management, patient-centered outcomes, and cardi-
ometabolic outcomes compared to wait-list controls and
that improvements would be greatest for patients
exposed to ATSM with an enhanced medication activa-
tion communication strategy triggered by pharmacy
claims and self-reported medication non-adherence.
Methods/Design
Study aims
Among ethnically and linguistically diverse persons with
diabetes receiving care in a primary care safety net
system:
Primary Aim: To investigate differences in 6-month
changes in patient-centered outcomes including quality
Ratanawongsa et al. BMC Health Services Research 2012, 12:22
http://www.biomedcentral.com/1472-6963/12/22
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spent in bed due to illness), comparing patients exposed
to ATSM with wait-list controls and comparing patients
exposed to ATSM (SMARTSteps-ONLY) with ATSM
augmented by medication adherence and intensification
(SMARTSteps-PLUS).
Secondary Aims: To investigate differences in 6-month
changes in diabetes self-management behaviors and self-
efficacy, patient-centered processes of care, cardiometa-
bolic outcomes (HbA1c, blood pressure, and LDL),
receipt of recommended health services, and healthcare
utilization, comparing patients exposed to ATSM with
wait-list controls and comparing patients exposed to
ATSM (SMARTSteps-ONLY) with ATSM augmented
by medication adherence and intensification (SMART-
Steps-PLUS).
Study Design
The study was a controlled quasi-experimental evalua-
tion trial with a wait-list variant of a stepped wedge
design (see Figure 1), which has been described pre-
viously in the implementation science literature [40-42].
This design is characterized by staggered introduction of
an intervention over time, cross-over of individual
patients from control to intervention arm at designated
times, and multiple data collection points. A stepped
wedge design allows for practical allocation of interven-
tion resources over time, with introduction of the inter-
vention in stages, such that all members receive the
intervention eventually, while still retaining elements of
a controlled trial [40]. Compared with a randomized
clinical trial, or a simple before and after design, the
stepped wedge design was more acceptable to SFHP,
which felt it would be unethical to deny some members
ATSM as a covered benefit while offering it to others,
given prior evidence of ATSM’sp o s i t i v ei m p a c to n
health outcomes. This design also allowed SFHP to
scale up recruitment and implementation in a controlled
fashion, with less intensive staffing than required if
offering the intervention to all eligible members at pro-
ject initiation (as in a cluster randomized design).
Finally, conducting four recruitment waves over 24
months allowed for collection of intervention and con-
trol data across multiple waves, allowing analysis to take
into account possible variations over time [40].
Study Setting
The study sample was drawn from SFHP members who
received primary care at one of four publicly-funded
clinics in the Community Health Network of San Fran-
cisco (CHNSF). SFHP is a non-profit Medicaid managed
care plan created in 1994 to provide high quality medi-
cal care to the largest possible number of low-income
San Francisco residents. In addition to managing Medi-
caid benefits, SFHP administers “Healthy Workers,” an
i n s u r a n c ep r o g r a mf o rp e o p l ew o r k i n ga si n - h o m es u p -
port service providers for elderly or disabled people in
San Francisco. At the time SFHP contacted the UCSF
investigative team in 2008, it managed the care of
approximately 50,000 enrollees and served an ethnically
diverse population comprised of 48% Asian-Americans,
26% Latinos, 12% African-Americans; 60% of their
membership were non-English speaking.
CHNSF is the integrated healthcare delivery system of
the San Francisco Department of Public Health and part
of the UCSF San Francisco Bay Area Collaborative
Research Network, one of the longest standing U.S.
practice-based research networks (http://familymedicine.
medschool.ucsf.edu/research/research_programs/crn/crn.
aspx). CHNSF is comprised of 12 community health
centers and hospital-based clinics centers affiliated with
the county’s acute care facility, San Francisco General
Hospital. CHNSF maintains a single electronic medical
information system with unique patient identifiers
across the clinical sites and a clinical registry that inte-
grates patient data such as diagnoses, vital signs, and
laboratory data.
Study sample
Eligibility criteria
Eligible participants were characterized by the following:
SFHP membership; ≥1 primary care clinic visit in the
preceding 24 months at one of our designated clinics;
age 18 or above; a diagnosis of diabetes (type 1 or 2);
English-, Cantonese-, or Spanish-speaking; access to a
touch-tone phone; and plans to remain in the region
during the evaluation period (12 months). Patients who
6 months  6 months  6 months  6 months  6 months  6 months 
N=182 INT  INT  WL1INT  INT  WL2INT  INT  WL3INT   WL4INT 
                     
Wave 1  Wave 2  Wave 3  Wave 4 
N=180 WL1  WL2  WL3  WL4 
          
April 2009                                                                                                            March 2011 
Figure 1 Quasi-experimental evaluation trial design of
SMARTSteps, a language-concordant automated telephone
diabetes self-management health plan intervention. INT =
Intervention Group, WL = Wait-list Group, WLINT = Wait-list Group
Turned Intervention (after 6 months). Represented in the figure are
182 Medicaid managed care plan members who were randomized
to intervention and 180 who were randomized to wait-list over the
entire study period. Each 6-month enrollment phase (the boxes
identified as ‘waves’) had patients going directly into an
intervention arm (INT) or wait-list for 6 months (WL). Each wave of
wait-list patients was then crossed-over into intervention after 6
months (WLINT). The dots represent the cross-over for individuals
on wait-list (WL) into the active intervention arm (WLINT).
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excluded. The diagnosis of diabetes was assessed in two
ways. First, we searched for SFHP members in the
CHNSF electronic diabetes registry. Second, we searched
for members with SFHP claims data consistent with dia-
betes (ICD-9 codes for utilization and pharmacy claims
for oral or injectable glycemic medications or glucose
self-monitoring supplies). If members were identified
through SFHP claims data but were not found in the
registry, we validated the diabetes diagnosis by reviewing
electronic health records for fasting glucose ≥ 126 mg/dl
and/or clinician-documented diagnosis of diabetes based
on HbA1c ≥ 7% [43]. During the course of the evalua-
tion trial, the American Diabetes Association revised
diagnostic criteria to include HbA1c ≥6.5% [44], but we
did not modify our eligibility criteria to avoid introdu-
cing selection bias and because evidence suggests a vari-
able delay in the adoption of guideline criteria by
practicing providers [45,46].
Sample recruitment procedures
SFHP mailed to potentially eligible members’ homes and
clinicians’ offices SMARTSteps post cards describing
this new benefit in English, Spanish, and Cantonese and
offering an SFHP number to call for information. SFHP
enrollment workers fluent in these three languages also
actively recruited potentially eligible health plan mem-
bers through scripted telephone calls. The enrollment
workers confirmed eligibility for SMARTSteps by phone
and offered $25 gift cards as incentives for participation.
All eligible members who reported interest in SMART-
Steps were then randomized by SFHP to one of four
intervention statuses (described below) regardless of
interest in the UCSF evaluation.
SFHP workers also assessed participant willingness to
complete evaluation interviews administered by UCSF
staff. Those members willing to participate in the inter-
views were then telephoned by UCSF research assistants
to obtain verbal consent for participation in the evalua-
tion interviews and were offered $50 gift cards as incen-
tives for each interview completed (up to $150).
Ethics approval
The Committee on Human Research at the University
of California, San Francisco (H9894-32044-01) approved
collection of interview data by UCSF from consenting
participants after obtaining verbal consent. Because all
recruitment and implementation was conducted by
SFHP by phone, it was felt that requiring a separate visit
to obtain written consent at UCSF or the primary care
clinic sites reduce participation, leading to selection
bias, and disrupt clinic workflow. Because the interviews
offered minimal risk, the Committee approved verbal
telephone consent for these interviews. In addition,
ethics approval included waiver of informed consent to
abstract and analyze CHNSF clinical data from the
CHNSF electronic health record, CHNSF diabetes regis-
try, SFHP claims data, and SFHP health coaching data
for all SFHP members eligible for SMARTSteps.
Study arms
All eligible SFHP members interested in the SMART-
Steps program were assigned by SFHP through lan-
guage-stratified randomization to one of four
intervention statuses: SMARTSteps-ONLY, SMART-
Steps-PLUS, wait-list for SMARTSteps-ONLY, or wait-
list for SMARTSteps-PLUS.
Wait-list Control
Those randomized to the wait-list continued to receive
usual care through their clinics, as well as all existing
SFHP benefits (reminders and incentives for receipt of
recommended health services, including laboratory test-
ing, eye and foot examination, and influenza vaccina-
tion) [43,47]. At the end of the 6-month wait-list period,
each participant “crossed-over” to begin SMARTSteps-
ONLY or SMARTSteps-PLUS, depending on initial ran-
domization arm.
SMARTSteps-ONLY
Participants randomized to SMARTSteps-ONLY received
the ATSM intervention within 2 weeks. Developed with
extensive input from patients to be sensitive to literacy,
language, and culture in the target populations [32], this
ATSM system provided 27 weeks of 8-12 minute weekly
calls in English, Cantonese, or Spanish. Patients specified
the weekday and time convenient for their schedules or
called toll-free into the system if they missed their sched-
uled call. The content consisted of rotating sets of
queries about self-care (such as diet, exercise, and medi-
cation adherence), psychosocial issues (such as depressive
symptoms), and access to preventive services (such as eye
care). Patients responded via touch-tone commands, and
based on their answers, patients heard automated health
education messages in the form of narratives.
Patients answering “out-of-range” on an item or
selecting a “call back” option received a telephone call
within 3 days from a language-concordant SFHP health
coach. This system was designed to promote health
coach efficiency and effectiveness by focusing outreach
calls to patients needing further support based on
ATSM responses. Health coaches provided education
and engaged in collaborative goal-setting to form
patient-centered action plans, a core process for self-
management support by which patients set short-term
goals to improve their self-management [20,35].
SFHP used a health coach for responding to ATSM
triggers, rather than a nurse practitioner care manager
as was done in the IDEALL trial [33]. Health coaches -
SFHP employees without a medical background or post-
graduate training - conducted phone calls under the
supervision of a registered nurse care manager. SFHP
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taught health coaches about diabetes and trained them
in behavior change counseling and overcoming barriers
to health communication. UCSF staff also guided the
development of written protocols and scripts to respond
to potential ATSM call triggers, such as assessing hypo-
glycemia symptoms or causes.
Health coaches documented the content of their
phone interactions, including patient-generated action
plans and whether they were achieved, using an SFHP
care management database system. SFHP health coaches
also contacted the designated clinic contact and/or the
primary care provider (PCP) using standardized tem-
plates for patients with pre-specified safety issues (such
as a new medical symptom) or access concerns (such as
need for refills or appointments). Non-urgent issues
were communicated by email or fax, while urgent issues
were also conveyed by phone.
Patients who indicated on their ATSM responses that
they missed their diabetes, blood pressure, or cholesterol
medications for 3-7 days in the previous week received
calls from health coaches to troubleshoot barriers to
adherence. These calls were only triggered by patient
self-disclosure in response to ATSM queries, unlike
adherence counseling calls triggered for SMARTSteps-
PLUS participants described below.
SMARTSteps-PLUS
The goal of the SMARTSteps-PLUS intervention was to
detect and intervene for participants whose medication
treatment was suboptimal, either because of non-adher-
ence or potential missed opportunities to intensify their
regimens. Because SFHP does not have prescribing
authorization for its members, the intervention focused
on enhancing medication regimens and adherence
through collaborative goal-setting with patients and
feedback to PCPs. Participants randomized to SMART-
Steps-PLUS immediately received the ATSM interven-
tion described above, as well as medication activation
and intensification coaching triggered by refill non-
adherence or suboptimal achievement of cardiometa-
bolic treatment goals. Based on review of evidence-
based guidelines [43], SFHP and UCSF collaborated to
develop a protocol to improve medication adherence
and promote patient-centered intensification by harnes-
sing electronically available data from two additional
sources: monthly SFHP pharmacy claims and clinical
laboratory and blood pressure data from the electronic
health records of the CHNSF.
The medication activation protocol targeted 3 groups
of patients within the SMARTSteps-PLUS arm (see Fig-
ure 2):
1. Patients who indicated in response to weekly ATSM
queries that they missed 3-7 days of medications in the
last week.
2. Patients with a 15-day to 6-month gap in refilling
specific cardiometabolic prescriptions: oral hypoglyce-
mic, insulin, anti-hypertensives (including ACE inhibi-
tors and angiotension-receptor blockers), cholesterol-
lowering medications, or glucose testing strips (for
patients receiving insulin or sulfonylureas), based on
pharmacy claims data. We chose a lower limit of 15-
days to account for potential delays in SFHP receipt of
pharmacy claims and an upper limit of 6 months in case
healthcare providers actively discontinued these
medications.
3. Patients with suboptimal achievement of cardiome-
tabolic goals [43]:
￿ Systolic blood pressure ≥ 130 mmHg at last
recorded check or no measurement in clinical regis-
try within preceding 6 months
￿ Diastolic blood pressure ≥ 80 mmHg at last
recorded check or no measurement in clinical regis-
try within preceding 6 months
￿ Hemoglobin A1c (HbA1c) > 7.0% on last measure-
ment or no measurement in clinical registry within
preceding 6 months
￿ Low-density lipoprotein (LDL) > 100 mg/dL on
last measurement or no measurement in clinical reg-
istry within preceding 12 months
￿ Urinary albumin/creatinine > 30 mcg/mg for
patients who were not prescribed or late to refill an
ACE inhibitor or angiotensin-receptor blocker
An individual SMARTSteps-PLUS participant could
fall into none, one, or more than one of these groups at
any given time. SFHP queried the pharmacy claims and
clinical registry data monthly to provide health coaches
with a list of SMARTSteps-PLUS participants to be
called.
For patients with evidence of non-adherence, SFHP
health coaches were trained with specific written proto-
cols and scripts to promote self-disclosure of medication
non-adherence and troubleshoot barriers such as confu-
sion about doses or frequency of medications, forgetful-
ness, concerns about side effects, or health beliefs (see
Additional File 1). For patients who had not had cardio-
metabolic measurements within guideline-concordant
timeframes, health coaches counseled patients about the
reasons for these measures, encouraged them to talk
with their providers, and notified PCPs of patients will-
ing to obtain these tests. For patients with suboptimal
achievement of treatment goals, health coaches were
trained to counsel patients about their blood pressure or
lab values and assess their willingness to discuss with
their PCPs the possibility of taking more medication.
Health coaches also encouraged patients to undergo
potential lifestyle changes. Based on their discussions,
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setting and action planning [20,35]. Health coaches then
notified the clinic contacts and/or PCPs about interac-
tions with any patients who needed laboratory or blood
pressure assessments, reported barriers to medication
adherence, or indicated a willingness to discuss medica-
tion intensification.
Study integrity
The study design conforms to CONSORT statement
recommendations for randomized trials of non-pharma-
cologic treatment [48]. Randomization to intervention
groups was conducted by SFHP before assessment of
willingness to participate in UCSF evaluation interviews
to permit analysis of primary outcomes. Intervention
arm assignment was conducted using a 4 × 4 blocked
randomized design, with the participant as the unit of
randomization. This randomization was completed for
each of the three study languages. Research assistants
administering the evaluation interviews were blinded to
group allocation. The intervention protocol is documen-
ted and filed on secure servers. Data generated during
ATSM and health coach calls is stored in the ATSM
and SFHP database systems, respectively. All analyses
will be intent-to-treat.
Measurement
Data Collection
Table 1 lists study outcomes.
For participants consenting to the UCSF evaluation
trial, measures of all primary and secondary patient-
reported outcomes were derived from structured inter-
views conducted in English, Spanish or Cantonese. For
Spanish and Cantonese interviews, survey questions
were translated and back-translated in their respective
languages. Interviews were administered using compu-
ter-assisted telephone interview (CATI) software or
paper survey, with responses later entered into the
Health Coach from Health Plan Calls Patient: 
•   Check understanding and educate regarding diabetes goals
•   Elicit barriers to adherence
•   Inform about current data & goals
•   Assess understanding of discussions with PCP 
•   Assess willingness to increase or add new medication to meet goals
•   Develop action plan using motivational interviewing principles
Health Coach Notifies Clinic If Member: 
•  Needs repeat testing OR
•  Is not taking medications as prescribed OR  
•  Is adherent to current regimen, is not at goal, and willing to intensify 
Suboptimal 
Goals on 
Clinical 
Registry 
Self-Reported 
Med Non-
Adherence on 
ATSM 
Responses  
Refill Non-
Adherence on 
Health Plan 
Pharmacy 
Claims 
Figure 2 SMARTSteps-PLUS protocol for automated telephone self-management (ATSM) with enhanced medication adherence and
intensification counseling.
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pleted baseline interviews within 2 weeks of being ran-
domized, prior to the first ATSM call. SMARTSteps-
ONLY and SMARTSteps-PLUS participants completed
the 6-month follow-up interviews after the conclusion
of their ATSM intervention, and wait-list participants
completed the 6-month follow-up interviews before the
start of their ATSM calls. Wait-list groups received an
additional 6-month follow-up interview (12 months after
enrollment) after completion of intervention period. Par-
ticipants received a $50 gift card for a pharmacy store at
the completion of each interview.
For all eligible SFHP members, we collected socio-
demographic variables and cardiometabolic outcomes
data using monthly downloads of SFHP claims data and
CHNSF clinical registry data. At the conclusion of the
project, we will obtain SFHP administrative and claims
data for utilization outcomes.
Socio-demographic variables
Self-reported socio-demographic variables included age,
gender, race/ethnicity, language, English proficiency,
years since immigration to the U.S., marital status, edu-
cational attainment, employment status, annual house-
hold income, self-reported health literacy [49,50], and
duration of diabetes. We obtained SFHP administrative
and CHNSF data regarding age and gender. Preferred
language is captured in both SFHP and CHNSF data,
and where this preference was discrepant, we used the
language reported to SFHP enrollment workers.
Primary and Secondary Patient-Reported Outcomes
The primary outcome variables are physical and mental
functional status (SF-12) and the number of days spent
in bed due to illness [51]. Secondary outcomes include
diabetes self-efficacy and self-management behavior, as
well as medication adherence in the preceding 7 days
[52-54]. Secondary outcomes also include patient per-
spectives on the structure of their care, as measured by
two instruments which have been translated and vali-
dated for our population in our prior work: Patient
Assessment of Care for Chronic Conditions (PACIC)
and interpersonal processes of care (IPC) [33,55,56].
Cardiometabolic Outcomes
These secondary outcomes will be analyzed on the lar-
ger set of SFHP participants randomized in the trial (N
= 362), regardless of whether or not they participated in
the evaluation interviews. Cardiometabolic outcomes
include measures of HbA1C, LDL, and blood pressure
obtained by clinical providers. Data will be derived from
CHNSF electronic health record, the clinical registry
database, and paper chart review. Values will be used at
baseline only if obtained within one year before program
enrollment. Follow-up laboratory and blood pressure
values will be included only if obtained within 90 days
before or after the 6-month and 12-month follow-up
dates.
Care Delivery Processes and Utilization
Finally, for all eligible participants, we will use SFHP
administrative claims data to examine measures of care
Table 1 Outcomes for SMARTSteps, a quasi-experimental evaluation trial of a language-concordant automated
telephone diabetes self-management health plan intervention
Variable Instrument
Primary outcome variables
Functional status SF-12 [51]
Days confined to bed due to illness
Secondary outcome variables
Diabetes self-management
behaviors
Summary of Diabetes Self-Care Activities (SDSCA) measure [52]
Self-reported medication adherence Summary of Diabetes Self-Care Activities (SDSCA) measure [52]
Diabetes self-efficacy Patient self-management scale derived from questionnaire used in the Diabetes Quality Improvement Project
[54]
Patient-centeredness of care Patient Assessment of Care for Chronic Conditions (PACIC) [55]
Interpersonal processes of care (IPC) [56]
Glycemic control Hemoglobin A1c
Blood pressure control Systolic and diastolic blood pressure
Cholesterol control Low-density lipoprotein
Quality of care Proportions receiving hemoglobin A1c and blood pressure measurement within 6 months [43,47]
Proportions receiving LDL and microalbumin/creatinine measurement within 12 months [43,47]
Proportion receiving retinal examination within 12 months [43,47]
Proportion receiving influenza and pneumococcal vaccination [43,47]
Utilization Emergency department
Hospitalization
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checks, laboratory testing, retinal examinations, influ-
enza vaccination, and pneumococcal vaccination at
guideline-concordant frequencies [43]. We will also
examine utilization, including the frequency of emer-
gency department visits and hospitalizations.
Program Engagement and Satisfaction
Using data from the ATSM system, we will assess
patient engagement as measured by exposure intensity
(defined as the proportion of the 27 weeks of exposure,
participants replied to the weekly calls) and the propor-
tion of weekly calls that are determined to be complete
(calls answered and responses to 100% of queries), par-
tially complete (call answered and responses to < 50% of
queries), and incomplete (call answered but responses to
0% of queries) [32]. In addition, using data from the
SFHP health coach database, we will analyze at the par-
ticipant level the number of health coach calls that were
triggered by ATSM responses; the number of calls
attempted and/or completed by health coaches; and the
number of action plans created and/or achieved, as
reported by patients and documented in the database.
We will conduct fidelity assessments to examine poten-
tial differential engagement across languages, clinics and
study arms. Finally, we will assess satisfaction and per-
ceived usefulness of the intervention as reported during
evaluation interviews at 6- and 12-month follow-up.
Data analyses
We will assess the similarity of baseline characteristics
between study arms using t-tests, chi-square tests, and
Fisher’s exact tests. We will control for any significant
differences in baseline characteristics in analyses of all
primary and secondary outcomes.
For each outcome, we will compare differences
between study arms in 6-month changes using intent-
to-treat analyses. Because this study is a quasi-experi-
mental evaluation trial with a wait-list variant of a
stepped wedge design, analyses of outcome changes
will be conducted with two distinct methodologies.
The first method will involve analyzing the data as if
the trial was a standard intervention versus control
study, comparing all participants who were randomized
to the ATSM intervention (either SMARTSteps-ONLY
or SMARTSteps-PLUS) versus all participants rando-
mized to the wait-list control groups. We will use lin-
ear regression for continuous variables, logistic
regression for dichotomous variables, and negative
binomial models for the outcome variable of number
of bed days because of its non-parametric data distri-
bution. We will include as model covariates the base-
line value of outcome variables and any socio-
demographic or medical variables that may have dif-
f e r e db yc h a n c ea m o n gt h eg r o u p s .
The second method will take advantage of the wait-list
variant, stepped wedge design with study cross-over of
participants from control to intervention [40]. It will
employ a repeated measures analysis using maximum
likelihood to fit the models. Because discrete external
events may coincide with the time that participants
cross-over from control to intervention and thereby pos-
sibly confound the within-group comparisons from the
wait-list control group, secular effects in the wait-list
group will be modeled first to see if a specific spline to
capture non-linearities analysis is needed or if a simple
linear trend exists, simplifying the analysis. Other possi-
ble covariates in the model may be calendar time, actual
time of intervention exposure, and predictors of drop-
ping out of study.
To explore the added value of the medication activa-
tion arm, both the first and second methods above will
also be used to compare SMARTSteps-ONLY versus
SMARTSteps-PLUS in all primary and secondary
outcomes.
Sample size calculations
Sample size calculations were based on comparison of
primary outcomes for the combined intervention groups
(SMARTSteps-ONLY and SMARTSteps-PLUS) with the
combined wait-list control groups. Based on an eligible
population of approximately 500 SFHP members, we
anticipated recruitment of 260 participants to interven-
tion and control with a 10% drop-out or loss to follow-up
rate at 6 months. Using a two-tailed test, we calculated
that we would have 80% power to detect a standardized
effect size (SE) of 0.35 in the primary outcome of SF-12
scores, comparing the combined intervention groups
with the combined wait-list groups. In the prior RCT, we
observed standardized effect sizes in this range [33].
We estimated that over the course of the two-year
observation period, approximately 20% of enrolled parti-
cipants would have insufficient data for secondary cardi-
ometabolic outcomes to be included in these analyses.
Under this assumption, we would have 80% power to
detect a difference in HbA1c of 0.51% (SE 0.28) when
comparing wait-list vs. combined ATSM interventions
participants. This effect size is intermediate between
that estimated to be the effect on glycemic control of
diabetes disease management programs that involve
team changes (-0.3% HbA1c improvement) and those
that involve medication intensification strategies (-0.6%)
[57].
Recruitment
Figure 3 shows the CONSORT diagram for recruitment
of participants into the SMARTSteps Project by SFHP
and into the UCSF evaluation. Of 910 SFHP members
originally assessed for eligibility, 548 were excluded: 220
did not meet inclusion criteria, 168 could not be
Ratanawongsa et al. BMC Health Services Research 2012, 12:22
http://www.biomedcentral.com/1472-6963/12/22
Page 8 of 13contacted, and 160 declined participation. Of note,
because SFHP membership was continually changing,
SFHP categorized people as “not eligible for SFHP” if
they had not been an active SFHP member for more
than a month and were not yet contacted by SFHP for
recruitment.
At close of evaluation trial, 362 patients were
enrolled and randomized for the SMARTSteps
 
Excluded (n= 548) 
 Not  meeting inclusion criteria (n=220) 
o  Not current SFHP member  
(n=84) 
o  No current diabetes  (n=69) 
o  Not active patient in assigned 
primary care clinic  (n=49) 
o Language    (n=14) 
o Moved  to new town or clinic (n=3) 
o Deceased  (n=1) 
  Unable to contact (n=168) 
o  No attempt  (n=79) 
o  Wrong phone number  (n=21) 
o  Unsuccessful contact  (n=68) 
 Declined  to  participate  (n=160) 
o  No reason given (n=33) 
o  Not interested (n=35) 
o Logistics  (n=46) 
o Health  status  (n=25) 
o  Have support (n=3) 
o  Want to consider (n=18) 
Intervention Groups: 
 Ineligible  (n=4) 
o  Not diabetic (n=2) 
o Language  (n=2) 
  Declined intervention (n=1) 
  Declined survey (n=17) 
 Unreachable  (n=11) 
Incomplete survey (n=4)
SMARTSteps 
ONLY 
(n=86) 
 
Assessed for Eligibility (n=910) 
SMARTSteps 
PLUS 
(n=96) 
 
Wait-list for 
SMARTSteps 
PLUS 
(n=94) 
Wait-list for 
SMARTSteps 
ONLY 
(n=86) 
Completed 
Baseline 
Survey 
(n= 72) 
Completed 
Baseline 
Survey 
(n=73) 
Completed 
Baseline 
Survey 
(n= 65) 
Completed 
Baseline 
Survey 
(n= 68) 
Randomized 
(n=362) 
Wait-List Groups: 
 Ineligible  (n=5) 
o  Not diabetic (n=2) 
o Language  (n=3) 
  Declined survey (n=18) 
 Unreachable  (n=21) 
 Deceased  (n=1) 
  Incomplete survey (n=2) 
Figure 3 Recruitment for SMARTSteps, a quasi-experimental evaluation trial of a language-concordant automated telephone diabetes
self-management health plan intervention.
Ratanawongsa et al. BMC Health Services Research 2012, 12:22
http://www.biomedcentral.com/1472-6963/12/22
Page 9 of 13program, with 278 completing baseline interviews for
the evaluation trial. Table 2 shows the socio-demo-
graphic and medical characteristics for those who
enrolled in SMARTSteps, SFHP members who
declined enrollment, and those who were not con-
tacted for recruitment (some of whom may have been
found ineligible if they had been contacted to complete
the eligibility screening survey). Compared with the
members who declined, SMARTSteps participants
were younger; more likely to be women, Hispanic/
Latino, and non-English-speaking; and less likely to be
white/Caucasian. Compared with non-contacted mem-
bers, SMARTSteps participants had LDL values and
were more likely to be non-English speaking and to
have Healthy Workers insurance.
With SF-12 scores on 278 patients at baseline, assum-
ing 10% loss to a 6-month follow-up sample of 250, we
would have an 80% power to detect a mean difference
of 2.85 in the SF-12 physical component score and 3.44
in the SF-12 mental component score.
Clinical registry data included available baseline
HbA1c values for 348 total patients. With an assump-
tion of 20% loss to follow-up, our study would have 80%
power to detect a HbA1c difference of 0.37%.
Discussion
The results of our recruitment process suggest that
ATSM with health coach counseling may be a viable
strategy for low-income managed care plans caring for
linguistically and culturally diverse vulnerable persons
Table 2 Baseline characteristics in SMARTSteps, a quasi-experimental evaluation trial of a language-concordant
automated telephone diabetes self-management health plan intervention
Characteristic Enrolled
(N = 362)
Declined (N = 160) p-value Non-Contacted (N = 168) p-value
Age in years, mean +/- SD 54.8 (8.4) 56.2 (9.2) 0.03 54.5 (10.9) 0.93
Female, n (%) 258 (71.3) 98 (61.3) 0.02 111 (66.1) 0.23
Race/ethnicity, n (%) < 0.01 0.10
Asian 212 (58.6) 97 (60.6) 84 (50.0)
Black/African-American 25 (6.9) 9 (5.6) 18 (10.7)
White/Caucasian 34 (9.4) 31 (19.4) 20 (11.9)
Latino/Hispanic 81 (22.4) 16 (10.0) 38 (22.6)
Native American/Eskimo 1 (0.3) 0 (0.0) 2 (1.2)
Hawaiian/Pacific Islander 3 (0.8) 0 (0.0) 0 (0.0)
Other 5 (1.4) 6 (3.8) 5 (3.0)
Unknown 1 (0.3) 1 (0.6) 1 (0.6)
Language, n (%) < 0.01 < 0.01
English 121 (33.4) 81 (50.6) 95 (56.5)
Spanish 61 (16.9) 6 (3.8) 22 (13.1)
Cantonese 180 (49.7) 73 (45.6) 51 (30.4)
Financial Class - Insurance Type, n (%) 0.83 0.04
Healthy Worker 255 (70.6) 112 (70.0) 95 (56.5)
Medicaid 82 (22.7) 35 (21.9) 53 (31.6)
Medicare 16 (4.4) 9 (5.6) 10 (6.0)
Healthy San Francisco 5 (1.4) 2 (1.3) 6 (3.6)
Uninsured 3 (0.8) 1 (0.6) 3 (1.8)
Commercial 0 (0.0) 1 (0.6) 1 (0.6)
Healthy Kids 1 (0.3) 0 (0.0) 0 (0.0)
Cardiometabolic Indicators, mean +/- SD
Hemoglobin A1c 7.7 (1.6) 7.6 (1.5) 0.09 7.9 (1.9) 0.82
Systolic blood pressure 128.6 (17.6) 128.8 (16.7) 0.80 131.6 (19.2) 0.38
Diastolic blood pressure 74.7 (11.2) 75.2 (11.0) 0.48 75.6 (10.2) 0.31
Low-density lipoprotein 95.0 (30.6) 95.0 (34.3) 0.99 105.2 (34.0) < 0.01
* All p-values were derived from chi-square tests for categorical variables, t-tests for interval variables if normally distributed and Wilcoxon tests if interval
variables not normally distributed (age and cardiometabolic indicators).
† P-values for race/ethnicity were calculated based on categories of Asian/Pacific Islander, Black/African-American, Hispanic/Latino, Native American/Other/
Unknown, and White/Caucasian.
‡P-values for financial class were calculated based on categories of Healthy Worker/Healthy San Francisco, Medicaid (Community Alternatives Program or Fee-For-
Service), Medicare, and Commercial/Uninsured.
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Page 10 of 13with diabetes using population-based recruitment. In the
IDEALL study, we found high levels of engagement, par-
ticularly with non-English speakers, and our early mea-
sures of reach suggest that this intervention model can
be scaled up for larger populations [32,33,37].
The quasi-experimental design of the SMARTSteps
evaluation trial offers a useful illustration of the advan-
tages and challenges of a wait-list variant of a stepped
wedge design. This design enabled all eligible SFHP
members to receive ATSM as a benefit and increased
the feasibility of scaling up the intervention through
recruitment waves, while retaining elements of randomi-
zation that help minimize bias. However, this design
requires careful evaluation of both intervention fidelity
and potential confounders over time as well as investiga-
tion into the impact of extended follow-up time, poten-
tial time trends, and the impact of clustering in the data
analysis strategy [40].
Translational evidence from safety net settings is
needed to understand whether HIT applications such as
ATSM can be effective in real-world settings and to
inform how to harness HIT to support chronic disease
self-management among vulnerable populations and
improve patient-centered outcomes. In response to
Medicaid and Medicare incentives arising from the 2009
Health Information Technology for Economic and Clini-
cal Health Act, safety net settings are required to inte-
grate electronic health records (EHRs) into the care
environment and meet “meaningful use” criteria, includ-
ing patient education and tracking of quality indicators
[58-60]. In addition, federal and state policy has steered
increasing numbers of vulnerable populations into capi-
tated, managed care arrangements, with some promising
results with respect to chronic disease outcomes and
disparities reductions [61]. Expanding HIT integration
among Medicaid managed health plans, provider groups,
and patients will increasingly be a critical avenue for
improving the health of vulnerable populations.
The results of this evaluation trial, when completed,
must be interpreted within the following limitations.
First, SFHP’s phone-based population recruitment tar-
geted different languages over time due to enrollment
worker availability, with greater emphasis on Cantonese-
speaking populations earlier. Thus, potential differences
in intervention impact by language may relate to
changes in project implementation over time. Second,
because SFHP does not have medication prescribing
authority for its members or authority to document
within participants’ medical records, the interventions
will not be fully-integrated into care delivery in the con-
text of participants’ medical homes; this may limit the
effectiveness of the intervention, particularly the
SMARTSteps-PLUS medication intensification arm.
Finally, because data for cardiometabolic outcomes relies
on collection through routine medical care rather than
scheduled study visits, we may not be powered to detect
a modest impact of the intervention on glycemic or
blood pressure control.
Improving health communication through the use of
tailored, proactive HIT is one scalable vehicle to
improve chronic disease care for vulnerable populations
[32,33]. Focusing on improving the processes of care for
vulnerable populations in under-resourced safety net
settings through the application of evidence-based or
evidence-informed HIT tools can have far-reaching
implications for bridging the clinical care-public health
divide, not only for diabetes, but for other chronic con-
ditions and for preventive services [27]. The SMART-
Steps outcomes will provide evidence regarding the real-
world implementation of ATSM within a Medicaid
managed care plan and provide insight into translating
and scaling up HIT interventions for linguistically and
culturally diverse vulnerablep o p u l a t i o n sw i t hc h r o n i c
disease.
Additional material
Additional file 1: SMARTSteps-PLUS medication intensification
scripts. This document offers an example of SMARTSteps-PLUS
medication intensification scripts for health coach phone calls in a quasi-
experimental evaluation trial of a language-concordant automated
telephone diabetes self-management health plan intervention.
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